This question concerns many people who use smokeless tobacco products, particularly within UK communities where betel quid and gutkha are common
Rapid weight loss, paradoxically, can also trigger fatty liver, as can total parenteral nutrition (intravenous feeding)
Consequences of smoking for body weight, body fat distribution, and insulin resistance
Studies show that quitting smoking may help lower inflammation and reduce the long-term risk of liver complications over time
Some observational studies suggest that patients with NAFLD who continue using tobacco products may have higher rates of advanced fibrosis compared to non-users with similar metabolic profiles, though the strength of evidence specific to smokeless tobacco remains uncertain
Viral Hepatitis: For individuals with hepatitis B or C, smoking accelerates liver damage and increases the risk of developing liver cirrhosis and hepatocellular carcinoma (liver cancer)